banner

Successful Grant Writing: Common Challenges and How to Overcome Them

For any start-up or small company, non-dilutive funding can become an essential component of a healthy financing mix. Government and non-government grants are abundantly available, on local, European and global levels. But for a starting business owner, grant management can come on top of all the other responsibilities they're already struggling to fit into their available time. This can result in missing out on obvious grant opportunities, wasting time on unfit grant applications, or even losing money due to non-compliant grant reporting.

Modis' grant consultants have years of experience in grant management and have seen many companies face very similar challenges. We will explain some of the main pitfalls in finding grants, writing applications and managing grant projects, and show you how to avoid them.

With only a few simple tips and tricks, you can turn your grant portfolio into a real asset for your company!

Programme

10:30

Registration opens, networking & introductions

11:00

Interactive info session (live streamed)

12:15

Networking lunch

13:00

Office hours: meet one-on-one the experts

*Only for selected companies.

 

15:00

Close

Event Details

Date:

Monday, February 10, 2020 (10:30 h - 15:00 h)

Location:

Johnson & Johnson Innovation – JLABS @ BE
30 Turnhoutseweg
Beerse 2340

Price:

You can find all registration prices here

Organiser(s):

Johnson & Johnson innovation (JLABS) in close collaboration with Modis

2020-02-10 10:30:00 2020-02-10 15:00:00 Europe/Brussels Successful Grant Writing: Common Challenges and How to Overcome Them Johnson &amp; Johnson Innovation – JLABS @ BE30 TurnhoutsewegBeerse 2340 <p>Johnson &amp; Johnson innovation (JLABS) in close collaboration with Modis</p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Communications Coordinator

Alternate Text

Sielke Brugge

Communications Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?